76045-212-10 · Dexamethasone Sodium Phosphate Injection · Fresenius Kabi USA, LLC
What is the status for 76045-212-10 · Dexamethasone Sodium Phosphate Injection · Fresenius Kabi USA, LLC?
For 76045-212-10, generic name is Dexamethasone Sodium Phosphate Injection; manufacturer is Fresenius Kabi USA, LLC; status is Current; availability now is Unavailable; initial posting date is 02/08/2019, recorded from its source on 2026-11-04.
"initial_posting_date": "02/08/2019", "package_ndc": "76045-212-10", "generic_name": "Dexamethasone Sodium Phosphate Injection", "contact_info": "888-386-1300", "availability": "Unavailable", "related_info": "Next release January 2027. Check wholesalers for inventory."
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 76045-212-10 verified
- Generic name
- Dexamethasone Sodium Phosphate Injection verified
- Manufacturer
- Fresenius Kabi USA, LLC verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Next release January 2027. Check wholesalers for inventory. verified
- Initial posting date
- 02/08/2019 verified
- Last update date
- 11/03/2026 verified
- Days in shortage
- 2826 our reading
- Reason for shortage
- Demand increase for the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Dermatology verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "11/03/2026", "therapeutic_category": [ "Dermatology", "Endocrinology/Metabolism", "Gastroenterology", "Hematology", "Neurology", "Oncology", "Ophthalmology", "Other", "Pulmonary/Allergy", "Rheumatology" ], "dosage_form": "Injection", "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10)", "company_name": "Fresenius Kabi USA, LLC", "shortage_reason": "Demand increase for the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000